Submitted by: Submitted by girmarco
Views: 10
Words: 475
Pages: 2
Category: Business and Industry
Date Submitted: 11/02/2016 11:36 PM
Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.
Published by: GIR (GlobalInfoResearch)
Catalog: Pharma & Healthcare
Publishing Date: Nov 2016
Single User License: USD 3480
Corporate Users License: USD 4680
Delivery time: 24 hours
Pages: 115
Tables and Figures: 142
Full information :[url]http://www.globalinforesearch.com/goods.php?id=1325[url]
Scope of the Report:
This report focuses on the Aprotinin in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Sigma-Aldrich
BeiJing Geyuantianrun Bio-tech
Cayman Chemical
Taj Pharmaceuticals Limited
Guangdong Techpool Bio-pharma
Dadeli
A.S.Joshi&Company
Enzymeking Biotechnology
AdooQ BioScience
ProSpec
Yaxin Biotechnology
AMRESCO
PanReac AppliChem
Runhao
Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
Latin America, Middle East and Africa
Market Segment by Type, covers
Aprotinin (From bovine lung)
Recombinant Aprotinin
Market Segment by Applications, can be divided into
Pharmaceuticals
Scientific Research & Experiment
There are 13 Chapters to deeply display the global Aprotinin market....